lactic acid has been researched along with Atrophy in 43 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Injectable poly-L-lactic acid (PLLA) is one type of filler that has been used to treat skin atrophy in patients with morphea and lupus erythematous panniculitis." | 8.02 | Novel use of poly-L-lactic acid filler for the treatment of facial cutaneous atrophy in patients with connective tissue disease. ( Euwer, R; Goff, HW; Gonzalez, CD; Pamatmat, JJ; Smart, D; Summers, E, 2021) |
| "Studies of injectable poly-L-lactic acid (PLLA) in human immunodeficiency virus (HIV)-associated facial lipoatrophy have predominantly included male Caucasians." | 7.78 | Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES). ( Bassichis, B; Blick, G; Conant, M; Condoluci, D; Daro-Kaftan, E; Echavez, M; Eviatar, J; Gold, MH; Hamilton, T; Hanke, CW; Humble, G; LaMarca, A; Mest, D; Pierone, G, 2012) |
| "A case of a unique combination of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like syndrome (MELAS) with acanthocytosis is reported." | 7.67 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with acanthocytosis: a clinicopathological study of a unique case. ( Kazui, H; Mukoyama, M; Nonaka, I; Satoyoshi, E; Sunohara, N; Yoshida, M, 1986) |
| " Forty patients were evaluated for adverse events (bruising, edema, erythema, subcutaneous papules) and satisfaction." | 5.36 | Modified poly-L-lactic acid injection technique: safety and efficacy of "cross-fanning" in non-HIV-related facial atrophy. ( Lee, JY; Schulman, MR; Skolnik, RA, 2010) |
| "Poly-L-lactic acid (PLLA) has been available to the European medical community as a treatment for Human Immunodeficiency Virus (HIV)-associated facial lipoatrophy for nearly a decade, gaining U." | 4.85 | Patient satisfaction and duration of effect with PLLA: a review of the literature. ( Goldman, MP; Palm, MD, 2009) |
| " Injectable poly-L-lactic acid (PLLA) is one type of filler that has been used to treat skin atrophy in patients with morphea and lupus erythematous panniculitis." | 4.02 | Novel use of poly-L-lactic acid filler for the treatment of facial cutaneous atrophy in patients with connective tissue disease. ( Euwer, R; Goff, HW; Gonzalez, CD; Pamatmat, JJ; Smart, D; Summers, E, 2021) |
| "Studies of injectable poly-L-lactic acid (PLLA) in human immunodeficiency virus (HIV)-associated facial lipoatrophy have predominantly included male Caucasians." | 3.78 | Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES). ( Bassichis, B; Blick, G; Conant, M; Condoluci, D; Daro-Kaftan, E; Echavez, M; Eviatar, J; Gold, MH; Hamilton, T; Hanke, CW; Humble, G; LaMarca, A; Mest, D; Pierone, G, 2012) |
| "Clinical features of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) resemble those of cerebral infarcts, but the pathogenesis of infarct-like lesions is not fully understood." | 3.70 | Serial diffusion-weighted imaging in MELAS. ( Imon, Y; Kajima, T; Katayama, S; Mimori, Y; Nakamura, S; Ohshita, T; Oka, M; Watanabe, C; Yamaguchi, S, 2000) |
| "MELAS is a mitochondrial cytopathy characterized by encephalopathy with stroke-like episodes and lactic acidosis." | 3.69 | [MELAS syndrome. Clinical aspects, MRI, biochemistry and molecular genetics]. ( Bachmann, G; Damian, MS; Dorndorf, W; Reichmann, H; Schachenmayr, W; Seibel, P, 1994) |
| "A case of a unique combination of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like syndrome (MELAS) with acanthocytosis is reported." | 3.67 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with acanthocytosis: a clinicopathological study of a unique case. ( Kazui, H; Mukoyama, M; Nonaka, I; Satoyoshi, E; Sunohara, N; Yoshida, M, 1986) |
| "Stroke is the main cause of acquired disability in adults." | 1.91 | Pre-stroke exercise does not reduce atrophy in healthy young adult mice. ( Brox, C; Christiansen, CL; Doosje, HL; Geiseler, SJ; Liesz, A; Morland, C; Nguyen, TD; Phan, KD; Tartanoglu, C, 2023) |
| " A questionnaire was used to evaluate patient satisfaction and the incidence of adverse reactions." | 1.40 | The safety and efficacy of poly-L-lactic acid on sunken cheeks in Asians. ( Kim, HS; Kim, SM; Lee, JD; Lee, SJ; Suh, DH, 2014) |
| "Atrophic scars represent a loss of collagen and a challenging reconstructive dilemma with disappointing traditional treatments." | 1.40 | Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid. ( Ozog, D; Rkein, A; Waibel, JS, 2014) |
| " Forty patients were evaluated for adverse events (bruising, edema, erythema, subcutaneous papules) and satisfaction." | 1.36 | Modified poly-L-lactic acid injection technique: safety and efficacy of "cross-fanning" in non-HIV-related facial atrophy. ( Lee, JY; Schulman, MR; Skolnik, RA, 2010) |
| "PEHO syndrome is a rare symptom complex of severe progressive encephalopathy, edema, hypsarrhythmia, and optic atrophy." | 1.33 | Serial MR imaging, diffusion tensor imaging, and MR spectroscopic findings in a child with progressive encephalopathy, edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome. ( Boltshauser, E; Huisman, TA; Klein, A; Straube, T; Werner, B, 2006) |
| "Alpers syndrome is a progressive encephalopathy of early onset, characterized by rapid and severe developmental delay, intractable seizures and liver involvement in a previously healthy child." | 1.31 | Respiratory chain deficiency in Alpers syndrome. ( Chrétien, D; Cormier-Daire, V; de Lonlay, P; Gauthier-Villars, M; Jacquemin, E; Landrieu, P; Munnich, A; Rötig, A; Rustin, P, 2001) |
| "Twelve percent ammonium lactate produced a significant sparing of atrophy in both the epidermis and dermis without any influence on the bioavailability or antiinflammatory properties of the corticosteroid." | 1.28 | Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid. ( Kaidbey, K; Lavker, RM; Leyden, JJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (11.63) | 18.7374 |
| 1990's | 5 (11.63) | 18.2507 |
| 2000's | 15 (34.88) | 29.6817 |
| 2010's | 13 (30.23) | 24.3611 |
| 2020's | 5 (11.63) | 2.80 |
| Authors | Studies |
|---|---|
| Pamatmat, JJ | 1 |
| Gonzalez, CD | 1 |
| Euwer, R | 1 |
| Summers, E | 1 |
| Smart, D | 1 |
| Goff, HW | 1 |
| Hiraki, N | 1 |
| Tanaka, TD | 1 |
| Yoshimura, M | 1 |
| Geiseler, SJ | 1 |
| Phan, KD | 1 |
| Brox, C | 1 |
| Nguyen, TD | 1 |
| Tartanoglu, C | 1 |
| Doosje, HL | 1 |
| Christiansen, CL | 1 |
| Liesz, A | 1 |
| Morland, C | 1 |
| Wong, ITY | 1 |
| Hanna, E | 1 |
| Pon, K | 1 |
| Yan, BY | 1 |
| Hibler, BP | 1 |
| Day, RA | 1 |
| Myskowski, PL | 1 |
| Rossi, AM | 1 |
| Eastham, AB | 1 |
| Liang, CA | 1 |
| Femia, AN | 1 |
| Lee, TC | 1 |
| Vleugels, RA | 1 |
| Merola, JF | 1 |
| Brodell, DW | 1 |
| Marchese Johnson, S | 1 |
| Suh, DH | 1 |
| Lee, SJ | 1 |
| Kim, SM | 1 |
| Lee, JD | 1 |
| Kim, HS | 1 |
| Rkein, A | 1 |
| Ozog, D | 1 |
| Waibel, JS | 1 |
| Kubozono, K | 1 |
| Takechi, M | 1 |
| Ohta, K | 1 |
| Ono, S | 1 |
| Nakagawa, T | 1 |
| Fujimoto, S | 1 |
| Kamata, N | 1 |
| Navajas, EV | 1 |
| Xu, K | 1 |
| Marcoux, J | 1 |
| McArthur, DA | 1 |
| Miller, C | 1 |
| Glenn, TC | 1 |
| Villablanca, P | 1 |
| Martin, NA | 1 |
| Hovda, DA | 1 |
| Alger, JR | 2 |
| Vespa, PM | 1 |
| Sadick, NS | 1 |
| Anderson, D | 1 |
| Werschler, WP | 1 |
| Palm, MD | 1 |
| Goldman, MP | 2 |
| Lee, JY | 1 |
| Schulman, MR | 1 |
| Skolnik, RA | 1 |
| Peyasantiwong, S | 1 |
| Loutfy, MR | 1 |
| Laporte, A | 1 |
| Coyte, PC | 1 |
| Maguina, P | 1 |
| Chaar, MY | 1 |
| Nadimi, S | 1 |
| Szczerba, SM | 1 |
| Chi, CS | 1 |
| Lee, HF | 1 |
| Tsai, CR | 1 |
| Chen, CC | 1 |
| Tung, JN | 1 |
| Fabi, SG | 1 |
| Bassichis, B | 1 |
| Blick, G | 1 |
| Conant, M | 1 |
| Condoluci, D | 1 |
| Echavez, M | 1 |
| Eviatar, J | 1 |
| Gold, MH | 1 |
| Hamilton, T | 1 |
| Hanke, CW | 1 |
| Humble, G | 1 |
| LaMarca, A | 1 |
| Daro-Kaftan, E | 1 |
| Mest, D | 1 |
| Pierone, G | 1 |
| Jakkani, R | 1 |
| Jyoti, S | 1 |
| Ahmed, M | 1 |
| Thomas, MM | 1 |
| Gambini, A | 1 |
| Falini, A | 1 |
| Moiola, L | 1 |
| Comi, G | 1 |
| Scotti, G | 1 |
| HEYCK, H | 1 |
| Louis, P | 1 |
| Holmes, J | 1 |
| Fernandes, R | 1 |
| Wu, GH | 1 |
| Wang, H | 1 |
| Zhang, YW | 1 |
| Wu, ZH | 1 |
| Wu, ZG | 1 |
| Qiao, T | 1 |
| Liu, C | 1 |
| Ran, F | 1 |
| Huisman, TA | 1 |
| Klein, A | 1 |
| Werner, B | 1 |
| Straube, T | 1 |
| Boltshauser, E | 1 |
| Sherman, RN | 1 |
| Keni, SP | 1 |
| Sidle, DM | 1 |
| Roc, AC | 1 |
| Ances, BM | 1 |
| Chawla, S | 1 |
| Korczykowski, M | 1 |
| Wolf, RL | 1 |
| Kolson, DL | 1 |
| Detre, JA | 1 |
| Poptani, H | 1 |
| Hoberg, B | 1 |
| Delank, HW | 1 |
| Odessey, R | 1 |
| Parr, B | 1 |
| Damian, MS | 1 |
| Reichmann, H | 1 |
| Seibel, P | 1 |
| Bachmann, G | 1 |
| Schachenmayr, W | 1 |
| Dorndorf, W | 1 |
| Tedeschi, G | 1 |
| Bertolino, A | 1 |
| Massaquoi, SG | 1 |
| Campbell, G | 1 |
| Patronas, NJ | 1 |
| Bonavita, S | 1 |
| Barnett, AS | 1 |
| Hallett, M | 1 |
| Bakker, HD | 1 |
| Van den Bogert, C | 1 |
| Drewes, JG | 1 |
| Barth, PG | 1 |
| Scholte, HR | 1 |
| Wanders, RJ | 1 |
| Ruitenbeek, W | 1 |
| Petschnig, R | 1 |
| Baron, R | 1 |
| Ohshita, T | 1 |
| Oka, M | 1 |
| Imon, Y | 1 |
| Watanabe, C | 1 |
| Katayama, S | 1 |
| Yamaguchi, S | 1 |
| Kajima, T | 1 |
| Mimori, Y | 1 |
| Nakamura, S | 1 |
| Giordano, G | 1 |
| Corradi, D | 1 |
| D'Adda, T | 1 |
| Melissari, M | 1 |
| Sijens, PE | 1 |
| den Heijer, T | 1 |
| de Leeuw, FE | 1 |
| de Groot, JC | 1 |
| Achten, E | 1 |
| Heijboer, RJ | 1 |
| Hofman, A | 1 |
| Breteler, MM | 1 |
| Oudkerk, M | 1 |
| Gauthier-Villars, M | 1 |
| Landrieu, P | 1 |
| Cormier-Daire, V | 1 |
| Jacquemin, E | 1 |
| Chrétien, D | 1 |
| Rötig, A | 1 |
| Rustin, P | 1 |
| Munnich, A | 1 |
| de Lonlay, P | 1 |
| Lavker, RM | 1 |
| Kaidbey, K | 1 |
| Leyden, JJ | 1 |
| Mukoyama, M | 1 |
| Kazui, H | 1 |
| Sunohara, N | 1 |
| Yoshida, M | 1 |
| Nonaka, I | 1 |
| Satoyoshi, E | 1 |
| Coventry, J | 1 |
| McEwan, D | 1 |
| Bertram, JD | 1 |
3 reviews available for lactic acid and Atrophy
| Article | Year |
|---|---|
Patient satisfaction and duration of effect with PLLA: a review of the literature.
Topics: Adipose Tissue; Atrophy; Cosmetic Techniques; Face; Female; HIV-Associated Lipodystrophy Syndrome; H | 2009 |
Hand rejuvenation: a review and our experience.
Topics: Adipose Tissue; Atrophy; Biocompatible Materials; Cosmetic Techniques; Durapatite; Hand; Humans; Hya | 2012 |
Sculptra (injectable poly-L-lactic acid).
Topics: Adipose Tissue; Atrophy; Cellulose; HIV Infections; Humans; Injections, Subcutaneous; Lactic Acid; M | 2007 |
1 trial available for lactic acid and Atrophy
| Article | Year |
|---|---|
Resorbable mesh as a containment system in reconstruction of the atrophic mandible fracture.
Topics: Absorbable Implants; Atrophy; Biocompatible Materials; Bone Transplantation; Fracture Fixation, Inte | 2004 |
39 other studies available for lactic acid and Atrophy
| Article | Year |
|---|---|
Novel use of poly-L-lactic acid filler for the treatment of facial cutaneous atrophy in patients with connective tissue disease.
Topics: Atrophy; Connective Tissue Diseases; Cosmetic Techniques; Humans; Lactic Acid; Polyesters; Polymers | 2021 |
A Man With Left Ventricular Hypertrophy.
Topics: Adult; Atrophy; Cardiomyopathies; Cerebellar Diseases; Cognitive Dysfunction; Echocardiography; Gluc | 2022 |
Pre-stroke exercise does not reduce atrophy in healthy young adult mice.
Topics: Animals; Atrophy; Brain; Disease Models, Animal; Humans; Infarction, Middle Cerebral Artery; Lactic | 2023 |
Poly-l-Lactic Acid for Treating Facial Lipoatrophy Secondary to Lupus Erythematosus Panniculitis.
Topics: Adult; Atrophy; Cellulose; Dermal Fillers; Face; Female; Humans; Lactic Acid; Mannitol; Panniculitis | 2021 |
Treatment of Facial Lipoatrophy Secondary to Subcutaneous Panniculitis-Like T-Cell Lymphoma.
Topics: Adult; Atrophy; Cellulose; Diagnosis, Differential; Drug Therapy, Combination; Facial Neoplasms; Fem | 2020 |
Lupus erythematosus panniculitis-induced facial atrophy: effective treatment with poly-L-lactic acid and hyaluronic acid dermal fillers.
Topics: Adult; Atrophy; Face; Female; Humans; Hyaluronic Acid; Lactic Acid; Panniculitis, Lupus Erythematosu | 2013 |
Use of intralesional poly-L-lactic acid in the treatment of corticosteroid-induced lipoatrophy.
Topics: Adipose Tissue; Adult; Atrophy; Female; Humans; Injections, Intralesional; Lactic Acid; Polyesters; | 2014 |
The safety and efficacy of poly-L-lactic acid on sunken cheeks in Asians.
Topics: Adipose Tissue; Adult; Aging; Asian People; Atrophy; Biocompatible Materials; Cheek; Contusions; Cos | 2014 |
Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Atrophy; Cicatrix; Collagen; Dermatologic Agents | 2014 |
Aesthetic recovery of alveolar atrophy following autogenous onlay bone grafting using interconnected porous hydroxyapatite ceramics (IP-CHA) and resorbable poly-L-lactic/polyglycolic acid screws: case report.
Topics: Absorbable Implants; Alveolar Ridge Augmentation; Atrophy; Autografts; Bone Screws; Bone Substitutes | 2014 |
Spectral-domain optical coherence tomography in mitochondrial encephalopathy, lactic acidosis, and strokelike episodes.
Topics: Adult; Atrophy; DNA, Mitochondrial; Electrooculography; Electroretinography; Female; Humans; Lactic | 2015 |
Persistent metabolic crisis as measured by elevated cerebral microdialysis lactate-pyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury.
Topics: Adolescent; Adult; Atrophy; Biomarkers; Brain Diseases; Brain Injuries; Chronic Disease; Cohort Stud | 2008 |
Addressing volume loss in hand rejuvenation: a report of clinical experience.
Topics: Adult; Aged; Atrophy; Cosmetic Techniques; Female; Hand; Humans; Lactic Acid; Male; Middle Aged; Pol | 2008 |
Modified poly-L-lactic acid injection technique: safety and efficacy of "cross-fanning" in non-HIV-related facial atrophy.
Topics: Atrophy; Biocompatible Materials; Cosmetic Techniques; Face; Health Surveys; HIV Infections; Humans; | 2010 |
An economic evaluation of treatments for HIV-associated facial lipoatrophy: a cost-utility analysis.
Topics: Adipose Tissue; Atrophy; Cost-Benefit Analysis; Face; HIV-Associated Lipodystrophy Syndrome; Humans; | 2010 |
Subcision with a wire dissector as an approach to human immunodeficiency virus lipoatrophy.
Topics: Atrophy; Face; HIV-Associated Lipodystrophy Syndrome; Humans; Injections; Lactic Acid; Male; Middle | 2010 |
Cranial magnetic resonance imaging findings in children with nonsyndromic mitochondrial diseases.
Topics: Adolescent; Atrophy; Brain; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Lact | 2011 |
Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
Topics: Adipose Tissue; Adult; Aged; Atrophy; Cosmetic Techniques; Female; HIV Infections; Humans; Injection | 2012 |
Magnetic resonance imaging findings in adult-form myotonic dystrophy type 1.
Topics: Adult; Atrophy; Brain; Cataract; Central Nervous System; Electromyography; Hearing Disorders; Humans | 2012 |
Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study.
Topics: Alcohol-Related Disorders; Atrophy; Choline; Corpus Callosum; Creatine; Demyelinating Diseases; Huma | 2003 |
[On the problem of cryptogenetic processes of brain atrophy: quantitative measurements of cerebral circulation and cerebral glucose, lactic acid and pyruvic acid metabolism].
Topics: Atrophy; Brain; Brain Diseases; Cerebrovascular Circulation; Glucose; Humans; Lactates; Lactic Acid; | 1961 |
Glutamine supplemented parenteral nutrition prevents intestinal ischemia- reperfusion injury in rats.
Topics: Animals; Atrophy; Bacterial Translocation; Glutamine; Intestinal Mucosa; Intestines; Lactic Acid; Ma | 2004 |
The impact of gastrocnemius muscle cell changes in chronic venous insufficiency.
Topics: Adult; Aged; Atrophy; Calcium-Transporting ATPases; Case-Control Studies; Electron Transport Complex | 2005 |
Serial MR imaging, diffusion tensor imaging, and MR spectroscopic findings in a child with progressive encephalopathy, edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome.
Topics: Aspartic Acid; Atrophy; Brain Diseases; Brain Edema; Cerebellum; Child; Choline; Creatine; Diffusion | 2006 |
Sculptra: the new three-dimensional filler.
Topics: Adipose Tissue; Atrophy; Cellulose; Face; Guidelines as Topic; Humans; Injections, Subcutaneous; Lac | 2006 |
Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
Topics: Adult; AIDS Dementia Complex; Antiretroviral Therapy, Highly Active; Aspartic Acid; Atrophy; Biomark | 2007 |
[Cerebrospinal fluid findings in brain atrophies detected by computer tomography].
Topics: Alcoholism; Atrophy; Brain; Brain Damage, Chronic; Brain Ischemia; Cerebrospinal Fluid Proteins; Enc | 1984 |
Effect of insulin and leucine on protein turnover in rat soleus muscle after burn injury.
Topics: Adenosine Triphosphate; Animals; Atrophy; Burns; Insulin; Lactates; Lactic Acid; Leucine; Male; Musc | 1982 |
[MELAS syndrome. Clinical aspects, MRI, biochemistry and molecular genetics].
Topics: Adolescent; Adult; Atrophy; Biopsy; Brain; Female; Follow-Up Studies; Humans; Lactates; Lactic Acid; | 1994 |
Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration.
Topics: Adult; Aged; Aspartic Acid; Atrophy; Cerebellar Diseases; Cerebellum; Choline; Creatine; Humans; Lac | 1996 |
Progressive generalized brain atrophy and infantile spasms associated with cytochrome c oxidase deficiency.
Topics: Acidosis; Atrophy; Brain; Cytochrome-c Oxidase Deficiency; Humans; Infant, Newborn; Lactates; Lactic | 1996 |
Assessment of metabolic response and functional changes after anterior cruciate ligament surgery.
Topics: Anaerobic Threshold; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Atrophy; Elect | 1997 |
Serial diffusion-weighted imaging in MELAS.
Topics: Adult; Atrophy; Brain; DNA, Mitochondrial; Echo-Planar Imaging; Female; Humans; Lactic Acid; Magneti | 2000 |
[An autopsy case of neonatal lactic acidosis].
Topics: Acidosis, Lactic; Atrophy; Autopsy; Body Fluids; Brain; Cardiomegaly; Epilepsy, Generalized; Fatal O | 2001 |
MR spectroscopy detection of lactate and lipid signals in the brains of healthy elderly people.
Topics: Aged; Aged, 80 and over; Aging; Atrophy; Brain; Brain Chemistry; Female; Humans; Lactic Acid; Lipids | 2001 |
Respiratory chain deficiency in Alpers syndrome.
Topics: Atrophy; Biopsy, Needle; Cerebral Cortex; Child, Preschool; Consanguinity; Diagnosis, Differential; | 2001 |
Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Atrophy; Biological Availability; Clobetas | 1992 |
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with acanthocytosis: a clinicopathological study of a unique case.
Topics: Acanthocytes; Acidosis; Adult; Aphasia; Atrophy; Biopsy; Cerebellum; Cerebral Cortex; Cerebral Ventr | 1986 |
Sterilisation of bulls with lactic acid.
Topics: Animals; Atrophy; Cattle; Lactates; Lactic Acid; Male; Orchiectomy; Testis | 1989 |